Literature DB >> 11683385

Genes for intermediate filament proteins and the draft sequence of the human genome: novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18.

M Hesse1, T M Magin, K Weber.   

Abstract

We screened the draft sequence of the human genome for genes that encode intermediate filament (IF) proteins in general, and keratins in particular. The draft covers nearly all previously established IF genes including the recent cDNA and gene additions, such as pancreatic keratin 23, synemin and the novel muscle protein syncoilin. In the draft, seven novel type II keratins were identified, presumably expressed in the hair follicle/epidermal appendages. In summary, 65 IF genes were detected, placing IF among the 100 largest gene families in humans. All functional keratin genes map to the two known keratin clusters on chromosomes 12 (type II plus keratin 18) and 17 (type I), whereas other IF genes are not clustered. Of the 208 keratin-related DNA sequences, only 49 reflect true keratin genes, whereas the majority describe inactive gene fragments and processed pseudogenes. Surprisingly, nearly 90% of these inactive genes relate specifically to the genes of keratins 8 and 18. Other keratin genes, as well as those that encode non-keratin IF proteins, lack either gene fragments/pseudogenes or have only a few derivatives. As parasitic derivatives of mature mRNAs, the processed pseudogenes of keratins 8 and 18 have invaded most chromosomes, often at several positions. We describe the limits of our analysis and discuss the striking unevenness of pseudogene derivation in the IF multigene family. Finally, we propose to extend the nomenclature of Moll and colleagues to any novel keratin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683385     DOI: 10.1242/jcs.114.14.2569

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  66 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

2.  Identification of a locus for type I punctate palmoplantar keratoderma on chromosome 15q22-q24.

Authors:  A Martinez-Mir; A Zlotogorski; D Londono; D Gordon; A Grunn; E Uribe; L Horev; I M Ruiz; N O Davalos; O Alayan; J Liu; T C Gilliam; J C Salas-Alanis; A M Christiano
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

3.  Functions and dysfunctions of the nuclear lamin Ig-fold domain in nuclear assembly, growth, and Emery-Dreifuss muscular dystrophy.

Authors:  Dale K Shumaker; Reynold I Lopez-Soler; Stephen A Adam; Harald Herrmann; Robert D Moir; Timothy P Spann; Robert D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-14       Impact factor: 11.205

Review 4.  Intermediate filaments in smooth muscle.

Authors:  Dale D Tang
Journal:  Am J Physiol Cell Physiol       Date:  2008-02-06       Impact factor: 4.249

Review 5.  Intermediate filaments: a historical perspective.

Authors:  Robert G Oshima
Journal:  Exp Cell Res       Date:  2007-04-11       Impact factor: 3.905

Review 6.  Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia.

Authors:  Hermann H Bragulla; Dominique G Homberger
Journal:  J Anat       Date:  2009-04       Impact factor: 2.610

Review 7.  Intermediate filaments: primary determinants of cell architecture and plasticity.

Authors:  Harald Herrmann; Sergei V Strelkov; Peter Burkhard; Ueli Aebi
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

Review 8.  "IF-pathies": a broad spectrum of intermediate filament-associated diseases.

Authors:  M Bishr Omary
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

9.  A role for intermediate filaments in determining and maintaining the shape of nerve cells.

Authors:  Brian T Helfand; Melissa G Mendez; Jason Pugh; Claude Delsert; Robert D Goldman
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

10.  Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells.

Authors:  Shubin Sheng; Daniel H Barnett; Benita S Katzenellenbogen
Journal:  Mol Cell Endocrinol       Date:  2008-10-04       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.